ArticleFrontiers in medicine2026
Hemoglobin glycation index and short-term mortality in sepsis: a retrospective cohort study with external validation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The hemoglobin glycation index (HGI) reflects interindividual variability in hemoglobin glycation beyond average glycemic exposure. Although stress-related dysglycemia is common in sepsis, the prognostic relevance of HGI in critically ill patients with sepsis remains unclear. Methods: We conducted a retrospective cohort study using the MIMIC-IV database ( Results: In the primary cohort, the 28-, 60-, and 90-day mortality rates were 23.25, 27.69, and 30.00%, respectively. Non-survivors exhibited significantly lower HGI levels than survivors ( Conclusion: Higher HGI was associated with lower short-term mortality in this retrospective cohort of critically ill patients with sepsis, with the strongest evidence observed for 28-day mortality. These findings suggest that HGI may provide prognostic information during the early phase of sepsis. Prospective studies are needed to validate these findings and determine their clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.